Cardio Diagnostics Jumps After Launching Blood Test For Early Detection Of Coronary Heart Disease

On:

Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.

PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.

CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Former BitMEX CEO Arthur Hayes On Why Bitcoin Price Has Likely Reached Bottom
  2. Cryptos Subdued Ahead Of Earnings Updates From Wall Street’s Tech Space
  3. Markets Digest China GDP Update
  4. MicroStrategy To Purchase More Bitcoin From Proceeds Of A $500 Million Stock Sale
  5. Lower Earnings Sends Fortrea Holdings Shares Down